I hadn’t planned on revisiting this topic again quite so soon, but sometimes a piece of information comes up that’s so disturbing that I can’t ignore it and can’t justify delaying blogging about it by very long. So it is yet again with the strange and disturbing saga of dichloroacetate (DCA), the small molecular chemotherapeutic […]
Share this:
Time passes. What once was new is old, and what once seemed far in the future is now just around the corner. In other words, the Skeptics’ Circle is rapidly approaching again; it’s a mere four days away! This time around, the 61st Meeting of the Skeptics’ Circle is scheduled to be hosted by Rebecca […]
Share this:
It would appear that I must respectfully disagree (or be Respectfully Insolent, if you will) with fellow comic fan Scott over at Polite Dissent. Two of my all-time favorite comics are Fantastic Four and (believe it or not, given my present day disdain for woo) Doctor Strange. Doctor Stephen Strange, for those of you not […]
Share this:
Abel Pharmboy shows why I shouldn’t have left my American Society of Clinical Oncology (ASCO) proceedings abstract sit on my desk unread for a week. Damn. Talk about blowing an opportunity. Of course, given that I don’t own any pharmaceutical stocks (making me a rather poor “tool of big pharma” indeed), it doesn’t matter.
